Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The future of radiosynoviorthesis: bright or bleak?
Freudenberg LS, Sewerin P, Ohlerth SM, Pomykala KL, Freudenberg S, Rischpler C, Lützen U. Freudenberg LS, et al. Among authors: pomykala kl. Q J Nucl Med Mol Imaging. 2022 Dec;66(4):345-351. doi: 10.23736/S1824-4785.22.03475-6. Epub 2022 Jun 16. Q J Nucl Med Mol Imaging. 2022. PMID: 35708602 Free article.
Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90Y Glass Microspheres.
Watanabe M, Grafe H, Theysohn J, Schaarschmidt B, Ludwig J, Jochheim L, Jeschke M, Schmidt H, Fendler WP, Moraitis A, Herrmann K, Pomykala KL, Weber M. Watanabe M, et al. Among authors: pomykala kl. J Nucl Med. 2023 Jul;64(7):1102-1108. doi: 10.2967/jnumed.122.264996. Epub 2023 Jun 8. J Nucl Med. 2023. PMID: 37290792
Molecular Imaging of Lymphoma: Future Directions and Perspectives.
Pomykala KL, Fendler WP, Vermesh O, Umutlu L, Herrmann K, Seifert R. Pomykala KL, et al. Semin Nucl Med. 2023 May;53(3):449-456. doi: 10.1053/j.semnuclmed.2022.10.003. Epub 2022 Nov 4. Semin Nucl Med. 2023. PMID: 36344325 Review.
Evaluation of thresholding methods for the quantification of [68Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy.
Kim M, Seifert R, Fragemann J, Kersting D, Murray J, Jonske F, Pomykala KL, Egger J, Fendler WP, Herrmann K, Kleesiek J. Kim M, et al. Among authors: pomykala kl. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2196-2209. doi: 10.1007/s00259-023-06163-x. Epub 2023 Mar 2. Eur J Nucl Med Mol Imaging. 2023. PMID: 36859618 Free PMC article.
Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma.
Ferdinandus J, Barbato F, Chodyla M, Fendler WP, Kessler L, Pomykala KL, Metzenmacher M, Krefting F, Hager T, Umutlu L, Herrmann K, Christoph DC. Ferdinandus J, et al. Among authors: pomykala kl. J Nucl Med. 2021 Feb;62(2):191-194. doi: 10.2967/jnumed.120.245803. Epub 2020 Jun 12. J Nucl Med. 2021. PMID: 32532926 Free article.
40 results